DocWire News Editors

DocwireNews

<p><em>This week&rsquo;s Cardio Round-up features a look back at what you may have missed during the holidays, as well as some of the big 2019 cardiology stories.</em><h2><a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/2019-in-cardiology-apple-heart-study-lands-icosapent-ethyl-gets-fda-nod-for-new-indication-dapagliflozin-for-nondiabetics-and-more/">2019 in Review: Apple Heart, Wearable Tech, and More</a></h2><p>The past year saw some big stories like the Apple Heart study, presented at ACC.19, which essentially validated the ability of a wearable device (an <a href="https://www.docwirenews.com/docwire-pick/future-of-medicine-picks/apple-watch-partners-with-zimmer-biomet-in-surgical-recovery-study/">Apple iWatch</a>) equipped with a tachogram-tracking algorithm was able to detect pulse irregularities associated with atrial fibrillation. Icosapent ethyl also featured prominently, gaining an FDA approval for the reduction of cardiovascular disease risk as an add-on to statin therapy in high-risk patients with hypertriglyceridemia. Dapagliflozin (highlighted in the DAPA-HF study) also was shown to be an effective treatment for heart failure in both diabetic and non-diabetic patients.</p><p>https://www.docwirenews.com/docwire-pick/cardiology-picks/2019-in-cardiology-apple-heart-study-lands-icosapent-ethyl-gets-fda-nod-for-new-indication-dapagliflozin-for-nondiabetics-and-more/</p><h2>AFib Prediction at the Individual Level?</h2><p>A new observational study published in<a href="https://academic.oup.com/europace/advance-article/doi/10.1093/europace/euz331/5678518" target="_blank" rel="nofollow noopener noreferrer"><em>&nbsp;Europace</em>&nbsp;</a>suggests it is possible to monitor and predict individual progression of&nbsp;<a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/american-indians-in-california-show-higher-risk-for-incident-afib/">atrial fibrillation</a> (AFib) using pacemakers or defibrillators.&ldquo;We aimed to study the progression of AER in individual patients with implantable devices and AFib episodes,&rdquo; the paper authors wrote. The study results indicated that the slope of AAR changes during the progression of AFib showed patient-specific patterns correlating with the time-to-completion of AER (<em>R</em><sup>2</sup> = 0.85).&nbsp; &ldquo;This technology opens up enormous possibilities in personalized medicine for AFib patients because it allows us to determine the progression rate of the arrhythmia in each individual and to optimize the timing of medical intervention with current treatment options,&rdquo; one of the researchers said in a press release.</p><p>https://www.docwirenews.com/docwire-pick/cardiology-picks/afib-how-electric-activity-in-the-heart-can-predict-individual-progression-of-atrial-fibrillation/</p><p>&nbsp;</p><h2><a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/afib-how-electric-activity-in-the-heart-can-predict-individual-progression-of-atrial-fibrillation/">Fat-Derived Stem Cells: Next-Gen Biologic Pacemakers?</a></h2><p>A research team, publishing the study in the <a href="https://www.sciencedirect.com/science/article/pii/S0022282819301968?via%3Dihub" target="_blank" rel="nofollow noopener noreferrer"><em>Journal of Molecular and Cellular Cardiology</em></a>, worked on converting adipogenic mesenchymal stem cells, which reside within fat cells, into cardiac progenitor cells. The ensuing cardiac progenitor cells can be programmed to aid heartbeats as a sinoatrial node (SAN), which is part of the electrical cardiac conduction system.&rdquo;We are reprogramming the cardiac progenitor cell and guiding it to become a conducting cell of the heart to conduct electrical current,&rdquo; said study co-author Bradley McConnell, associate professor of pharmacology, <a href="https://uh.edu/news-events/stories/2019/december-2019/121619-mcconnell-convert-fat-cells-to-pacemaker-like-cells.php">in a press release</a>. &ldquo;Results of this study show that the SHT5 combination of transcription factors can reprogram CPCs into Pacemaker-like cells.&rdquo;</p><p>https://www.docwirenews.com/docwire-pick/cardiology-picks/the-next-generation-of-biologic-pacemakers-new-discovery-in-stem-cells-from-fat-creates-another-alternative-treatment/</p><p>&nbsp;</p><h2><a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/diabetes-is-an-independent-predictor-for-heart-failure/">Diabetes Predictive of Heart Failure</a></h2><p>Diabetes mellitus is an independent predictor for <a href="https://www.docwirenews.com/conference-coverage/hfsa/">heart failure</a>, according to the findings of a study published in&nbsp;<em>Mayo Clinic Proceedings</em>. In this study, using the Rochester Epidemiology Project, researchers assessed the long-term impact of&nbsp;<a href="https://www.docwirenews.com/latest-internal-medicine-news/hypoglycemia-linked-frailty-mortality/">diabetes</a>&nbsp;on the development of heart failure by including 116 study subjects with diabetes, who were matched 1:2 based on age, hypertension, sex, coronary artery disease and diastolic with 232 participants without diabetes. The results showed that that diabetes is an independent risk factor for the development of heart failure. Over the duration of 10 years, 21% of participants with diabetes developed heart failure, independent of other causes. The researchers observed that by comparison, only 12% of patients without diabetes developed heart failure. &ldquo;The key takeaway is that diabetes mellitus alone is an independent risk factor for the development of heart failure,&rdquo; wrote one of the authors.</p><p>https://www.docwirenews.com/docwire-pick/cardiology-picks/diabetes-is-an-independent-predictor-for-heart-failure/</p><p>&nbsp;</p><h2><a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/quality-sleep-heart-disease/">Getting Enough Sleep Essential for Good Heart Health</a></h2><p>A new study suggests that regularly getting a good night&rsquo;s sleep isn&rsquo;t just a helpful overall health recommendation but is also an essential way to keep risk for heart disease and stroke down. The paper, published in the&nbsp;<a href="https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehz849/5678714" target="_blank" rel="nofollow noopener noreferrer"><em>European Journal of Cardiology</em></a>, included more than 300,000 participants initially free of cardiovascular disease (CVD) from UK Biobank. According to the results, there were 7,280 documented cases of incident CVD (4,667 coronary heart disease and 2,650 stroke) cases. Participants with a sleep score of 5 had a 35% reduced risk for CVD, a 34% reduced risk for coronary heart disease, and a 34% reduced risk for stroke when compared to participants with a score of 0-1.&nbsp;&ldquo;As with other findings from observational studies, our results indicate an association, not a causal relation,&rdquo; one of the authors said in a press release. &ldquo;However, these findings may motivate other investigations and, at least, suggest that it is essential to consider overall sleep behaviors when considering a person&rsquo;s risk of heart disease or stroke.&rdquo;</p><p>https://www.docwirenews.com/docwire-pick/cardiology-picks/quality-sleep-heart-disease/</p><p>&nbsp;</p></p>


Jayme Locke, MD, MPH

Joel M. Topf, MD, FACP

The Promise of Xenotransplantation

NKF Spring Clinical Meetings 2025

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Sacituzimab Govitecan Showed Modest Activity for CNS Metastases

Triple-Negative Breast Cancer

Latest News

Cardio Round-up:  Look Back at 2019, The Importance of Sleep, and More

Atrial Fibrillation

This week's Cardio Round-up features a look back at what you may have missed during the holidays, as well as some of the big 2019 cardiology stories. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe